ABCB1 p.Lys1099Glu

Predicted by SNAP2: A: N (72%), C: N (87%), D: N (53%), E: N (66%), F: N (78%), G: N (72%), H: N (97%), I: N (87%), L: N (82%), M: N (93%), N: N (82%), P: N (53%), Q: N (87%), R: N (97%), S: N (82%), T: N (93%), V: N (87%), W: D (53%), Y: N (93%),
Predicted by PROVEAN: A: N, C: D, D: N, E: N, F: N, G: D, H: N, I: N, L: N, M: N, N: N, P: N, Q: N, R: N, S: N, T: N, V: N, W: D, Y: N,

[switch to compact view]
Comments [show]
Publications
[hide] Zhou SF, Di YM, Chan E, Du YM, Chow VD, Xue CC, Lai X, Wang JC, Li CG, Tian M, Duan W
Clinical pharmacogenetics and potential application in personalized medicine.
Curr Drug Metab. 2008 Oct;9(8):738-84., [PMID:18855611]

Abstract [show]
Comments [show]
Sentences [show]

[hide] Wolf SJ, Bachtiar M, Wang J, Sim TS, Chong SS, Lee CG
An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics.
Pharmacogenomics J. 2011 Oct;11(5):315-25. doi: 10.1038/tpj.2011.16. Epub 2011 May 31., [PMID:21625253]

Abstract [show]
Comments [show]
Sentences [show]